BeyondSpring Inc.
General ticker "BYSI" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $74.2M (TTM average)
BeyondSpring Inc. does not follow the US Stock Market performance with the rate: -25.7%.
Estimated limits based on current volatility of 3.2%: low 0.60$, high 0.64$
Factors to consider:
- Total employees count: 25 as of 2016
- Top business risk factors: Limited operating history, Net losses continue, Need for additional capital, Plinabulin success dependent, Clinical trial failure
- Current price 50.7% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.24$, 2.90$]
- 2026-12-31 to 2027-12-31 estimated range: [1.21$, 2.80$]
Short-term BYSI quotes
Long-term BYSI plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $15.08MM | $8.75MM | $8.95MM |
| Operating Income | $-15.08MM | $-8.75MM | $-8.95MM |
| Non-Operating Income | $1.16MM | $-0.01MM | $0.32MM |
| R&D Expense | $7.27MM | $2.64MM | $4.39MM |
| Income(Loss) | $-13.92MM | $-8.77MM | $-8.62MM |
| Taxes | $0.09MM | $0.10MM | $-0.09MM |
| Other Income(Loss) | $-7.91MM | $-7.83MM | $-5.50MM |
| Net Income(Loss)* | $-21.03MM | $-11.12MM | $-8.54MM |
| Stockholders Equity | $-26.80MM | $-32.90MM | $-32.16MM |
| Assets | $24.81MM | $34.31MM | $25.93MM |
| Operating Cash Flow | $-16.47MM | $-16.44MM | $-20.02MM |
| Capital expenditure | $0.10MM | $0.22MM | $0.05MM |
| Investing Cash Flow | $-0.10MM | $-12.01MM | $13.48MM |
| Financing Cash Flow | $0.00MM | $26.79MM | $2.27MM |
| Earnings Per Share** | $-0.54 | $-0.28 | $-0.21 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.